Apogee Therapeutics, Inc.
APGE
16 insider filings · Latest: May 6, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | May 13 2:34 PM | HENDERSON MICHAEL THOMAS | Proposed Sale | 60,000 | $82.47 | $4.9M | — | View → |
| May 6, 2026 | May 9 12:00 AM | Carl DambkowskiChief Medical Officer | Sale | 5,500 | $84.14 | $462.8K | 207,023(D) | View → |
| May 6, 2026 | May 6 8:25 PM | CARL DAMBKOWSKI | Proposed Sale | 22,000 | $83.29 | $1.8M | — | View → |
| May 1, 2026 | May 5 12:00 AM | Jane HendersonChief Financial Officer | Sale | 2,000 | $82.04 | $164.1K | 173,371(D) | View → |
| May 1, 2026 | May 1 8:45 PM | JANE HENDERSON | Proposed Sale | 2,000 | $82.89 | $165.8K | — | View → |
| Apr 16, 2026 | Apr 18 12:00 AM | Jane HendersonChief Financial Officer | Sale | 2,000 | $90.00 | $180.0K | 175,371(D) | View → |
| Apr 8, 2026 | Apr 11 12:00 AM | Michael Thomas HendersonDirector, Chief Executive Officer | Sale | 20,000 | $82.58 | $1.7M | 1,132,987(D) | View → |
| Apr 1, 2026 | Apr 4 12:00 AM | Carl DambkowskiChief Medical Officer | Sale | 5,500 | $84.84 | $466.6K | 208,398(D) | View → |
| Apr 1, 2026 | Apr 4 12:00 AM | Jane HendersonChief Financial Officer | Sale | 2,000 | $85.01 | $170.0K | 177,371(D) | View → |
| Mar 25, 2026 | Mar 28 12:00 AM | Jane HendersonChief Financial Officer | Sale | 2,000 | $85.00 | $170.0K | 179,371(D) | View → |
| Mar 25, 2026 | Mar 25 8:24 PM | JANE HENDERSON | Proposed Sale | 6,000 | $73.00 | $438.0K | — | View → |
| Mar 11, 2026 | Mar 14 12:00 AM | Michael Thomas HendersonDirector, Chief Executive Officer | Sale | 20,000 | $74.78 | $1.5M | 1,152,987(D) | View → |
| Mar 4, 2026 | Mar 7 1:00 AM | Carl DambkowskiChief Medical Officer | Sale | 5,500 | $71.06 | $390.8K | 209,773(D) | View → |
| Mar 2, 2026 | Mar 5 1:00 AM | Jane HendersonChief Financial Officer | Sale | 2,000 | $70.22 | $140.4K | 181,371(D) | View → |
| Feb 11, 2026 | Feb 14 1:00 AM | Michael Thomas HendersonDirector, Chief Executive Officer | Sale | 20,000 | $63.35 | $1.3M | 1,172,987(D) | View → |
| Feb 11, 2026 | Feb 11 3:42 PM | HENDERSON MICHAEL THOMAS | Proposed Sale | 60,000 | $64.00 | $3.8M | — | View → |
| Feb 4, 2026 | Feb 5 1:02 AM | Carl DambkowskiChief Medical Officer | Sale | 5,500 | $65.79 | $361.9K | 211,148(D) | View → |
| Feb 2, 2026 | Feb 5 1:01 AM | Jane HendersonChief Financial Officer | Sale | 2,000 | $65.81 | $131.6K | 183,371(D) | View → |
| Jan 22, 2026 | Jan 23 1:07 AM | Fairmount Funds Management LLCDirector | Sale | 1,750,000 | $76.30 | $133.5M | 298,647(I) | View → |
| Jan 22, 2026 | Jan 23 1:03 AM | Fairmount Healthcare Fund II L.P. | Proposed Sale | 1,750,000 | $76.30 | $133.5M | — | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 6, 2026 | May 9 12:00 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 123,040(D) | View → |
| Apr 16, 2026 | Apr 20 8:05 PM | Michael Thomas HendersonDirector, Chief Executive Officer | Option Exercise | 3,000 | $22.86 | 387,012(D) | View → |
| Apr 1, 2026 | Apr 4 12:00 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 127,165(D) | View → |
| Mar 4, 2026 | Mar 7 1:00 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 131,290(D) | View → |
| Feb 4, 2026 | Feb 5 1:02 AM | Carl DambkowskiChief Medical Officer | Option Exercise | 4,125 | $22.86 | 135,415(D) | View → |